58,950 Shares in Lam Research Co. (NASDAQ:LRCX) Purchased by E. Ohman J or Asset Management AB

Lam Research logo with Computer and Technology background

E. Ohman J or Asset Management AB purchased a new position in shares of Lam Research Co. (NASDAQ:LRCX - Free Report) during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 58,950 shares of the semiconductor company's stock, valued at approximately $4,258,000.

A number of other institutional investors have also recently modified their holdings of LRCX. Mather Group LLC. raised its position in Lam Research by 797.8% during the fourth quarter. Mather Group LLC. now owns 16,206 shares of the semiconductor company's stock worth $1,171,000 after acquiring an additional 14,401 shares during the period. Stephens Consulting LLC increased its position in Lam Research by 900.0% during the fourth quarter. Stephens Consulting LLC now owns 430 shares of the semiconductor company's stock worth $31,000 after purchasing an additional 387 shares during the last quarter. Brown Lisle Cummings Inc. increased its stake in Lam Research by 1,712.5% during the fourth quarter. Brown Lisle Cummings Inc. now owns 1,450 shares of the semiconductor company's stock worth $105,000 after acquiring an additional 1,370 shares during the last quarter. Sloy Dahl & Holst LLC raised its holdings in Lam Research by 900.0% in the 4th quarter. Sloy Dahl & Holst LLC now owns 17,430 shares of the semiconductor company's stock valued at $1,259,000 after buying an additional 15,687 shares during the period. Finally, Tandem Capital Management Corp ADV lifted its holdings in shares of Lam Research by 900.0% in the 4th quarter. Tandem Capital Management Corp ADV now owns 5,100 shares of the semiconductor company's stock worth $368,000 after acquiring an additional 4,590 shares during the last quarter. 84.61% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

LRCX has been the subject of a number of research reports. Wolfe Research cut shares of Lam Research from an "outperform" rating to a "peer perform" rating in a report on Wednesday, January 15th. Barclays lowered their target price on shares of Lam Research from $90.00 to $75.00 and set an "equal weight" rating for the company in a report on Friday, January 17th. B. Riley cut their price target on Lam Research from $132.50 to $105.00 and set a "buy" rating on the stock in a research report on Wednesday, October 23rd. Sanford C. Bernstein upgraded shares of Lam Research from a "market perform" rating to an "outperform" rating and increased their target price for the stock from $85.00 to $91.00 in a research note on Thursday, January 30th. Finally, Mizuho cut their price objective on shares of Lam Research from $95.00 to $90.00 and set an "outperform" rating for the company in a research report on Friday, January 10th. Seven equities research analysts have rated the stock with a hold rating and sixteen have assigned a buy rating to the company's stock. According to data from MarketBeat, the company currently has a consensus rating of "Moderate Buy" and a consensus price target of $95.72.

Get Our Latest Analysis on LRCX

Lam Research Trading Up 1.1 %

Shares of LRCX traded up $0.89 during trading hours on Thursday, hitting $82.83. The stock had a trading volume of 9,887,924 shares, compared to its average volume of 12,681,168. The firm has a market cap of $106.58 billion, a P/E ratio of 25.16, a P/E/G ratio of 1.34 and a beta of 1.46. The company has a debt-to-equity ratio of 0.51, a quick ratio of 1.73 and a current ratio of 2.54. The company's fifty day simple moving average is $76.53 and its 200 day simple moving average is $78.26. Lam Research Co. has a 12-month low of $68.87 and a 12-month high of $113.00.

Lam Research (NASDAQ:LRCX - Get Free Report) last issued its earnings results on Wednesday, January 29th. The semiconductor company reported $0.91 EPS for the quarter, beating analysts' consensus estimates of $0.87 by $0.04. Lam Research had a net margin of 26.49% and a return on equity of 51.86%. Equities research analysts forecast that Lam Research Co. will post 3.69 EPS for the current fiscal year.

Lam Research Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Wednesday, April 9th. Stockholders of record on Wednesday, March 5th will be given a dividend of $0.23 per share. This represents a $0.92 dividend on an annualized basis and a dividend yield of 1.11%. Lam Research's payout ratio is currently 27.95%.

Lam Research Profile

(Free Report)

Lam Research Corporation designs, manufactures, markets, refurbishes, and services semiconductor processing equipment used in the fabrication of integrated circuits. The company offers ALTUS systems to deposit conformal films for tungsten metallization applications; SABRE electrochemical deposition products for copper interconnect transition that offers copper damascene manufacturing; SOLA ultraviolet thermal processing products for film treatments; and VECTOR plasma-enhanced CVD ALD products.

Featured Articles

Institutional Ownership by Quarter for Lam Research (NASDAQ:LRCX)

Should You Invest $1,000 in Lam Research Right Now?

Before you consider Lam Research, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Lam Research wasn't on the list.

While Lam Research currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

2025 Gold Forecast: A Perfect Storm for Demand Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

The Future of Healthcare: 3 AI Stocks Leading the Way

The Future of Healthcare: 3 AI Stocks Leading the Way

2025 promises explosive growth for AI, but which companies are making a difference in healthcare? Chris Markoch highlights three stocks leading the charge.

Recent Videos

7 Inflation-Proof Stocks to Protect Your Portfolio
Palantir’s Explosive Growth: Buy Now or Wait for a Dip?
5 Stocks to BUY NOW in February 2025

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines